News

Medical Dialogues20h
Bayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular carcinoma patients
Berlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational ...
News-Medical.Net on MSN1h
Semaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial shows
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...